223 related articles for article (PubMed ID: 16161007)
1. Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours.
Allia E; Tarabra E; Volante M; Cerrato M; Ghigo E; Muccioli G; Papotti M
J Pathol; 2005 Nov; 207(3):336-45. PubMed ID: 16161007
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin, cortistatin and their receptors in tumours.
Volante M; Rosas R; Allìa E; Granata R; Baragli A; Muccioli G; Papotti M
Mol Cell Endocrinol; 2008 May; 286(1-2):219-29. PubMed ID: 18248880
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of somatostatin and cortistatin receptors.
Siehler S; Nunn C; Hannon J; Feuerbach D; Hoyer D
Mol Cell Endocrinol; 2008 May; 286(1-2):26-34. PubMed ID: 18243519
[TBL] [Abstract][Full Text] [Related]
4. Distribution pattern of somatostatin and cortistatin mRNA in human central and peripheral tissues.
Dalm VA; Van Hagen PM; de Krijger RR; Kros JM; Van Koetsveld PM; Van Der Lely AJ; Lamberts SW; Hofland LJ
Clin Endocrinol (Oxf); 2004 May; 60(5):625-9. PubMed ID: 15104567
[TBL] [Abstract][Full Text] [Related]
5. The role of cortistatin in the human immune system.
van Hagen PM; Dalm VA; Staal F; Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):141-7. PubMed ID: 18450367
[TBL] [Abstract][Full Text] [Related]
6. Cortistatin - a new neuroendocrine hormone?
Rubinfeld H; Shimon I
Pediatr Endocrinol Rev; 2006 Dec-2007 Jan; 4(2):106-10. PubMed ID: 17342027
[TBL] [Abstract][Full Text] [Related]
7. Are somatostatin and cortistatin two siblings in regulating endocrine secretions? In vitro work ahead.
Gahete MD; Durán-Prado M; Luque RM; Martínez-Fuentes AJ; Vázquez-Martínez R; Malagón MM; Castaño JP
Mol Cell Endocrinol; 2008 May; 286(1-2):128-34. PubMed ID: 18215456
[TBL] [Abstract][Full Text] [Related]
8. Brain-gut communication: cortistatin, somatostatin and ghrelin.
Broglio F; Papotti M; Muccioli G; Ghigo E
Trends Endocrinol Metab; 2007 Aug; 18(6):246-51. PubMed ID: 17632010
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin, cortistatin, ghrelin and glucose metabolism.
Gauna C; van der Lely AJ
J Endocrinol Invest; 2005; 28(11 Suppl International):127-31. PubMed ID: 16625861
[TBL] [Abstract][Full Text] [Related]
10. Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line.
Cassoni P; Allia E; Marrocco T; Ghè C; Ghigo E; Muccioli G; Papotti M
J Endocrinol Invest; 2006 Oct; 29(9):781-90. PubMed ID: 17114908
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system.
Ferone D; Boschetti M; Resmini E; Giusti M; Albanese V; Goglia U; Albertelli M; Vera L; Bianchi F; Minuto F
Ann N Y Acad Sci; 2006 Jun; 1069():129-44. PubMed ID: 16855140
[TBL] [Abstract][Full Text] [Related]
12. Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth.
Volante M; Rosas R; Ceppi P; Rapa I; Cassoni P; Wiedenmann B; Settanni F; Granata R; Papotti M
J Pathol; 2009 Aug; 218(4):458-66. PubMed ID: 19373849
[TBL] [Abstract][Full Text] [Related]
13. Cortistatin and pituitary hormone secretion in rat.
Baranowska B; Bik W; Baranowska-Bik A; Wolinska-Witort E; Chmielowska M; Martynska L
J Physiol Pharmacol; 2009 Mar; 60(1):151-6. PubMed ID: 19439817
[TBL] [Abstract][Full Text] [Related]
14. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
[TBL] [Abstract][Full Text] [Related]
15. Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides.
Kamohara M; Matsuo A; Takasaki J; Kohda M; Matsumoto M; Matsumoto S; Soga T; Hiyama H; Kobori M; Katou M
Biochem Biophys Res Commun; 2005 May; 330(4):1146-52. PubMed ID: 15823563
[TBL] [Abstract][Full Text] [Related]
16. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W
J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444
[TBL] [Abstract][Full Text] [Related]
17. RT-PCR and immunocytochemistry studies support the presence of somatostatin, cortistatin and somatostatin receptor subtypes in rat Kupffer cells.
Xidakis C; Mastrodimou N; Notas G; Renieri E; Kolios G; Kouroumalis E; Thermos K
Regul Pept; 2007 Oct; 143(1-3):76-82. PubMed ID: 17481746
[TBL] [Abstract][Full Text] [Related]
18. Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans.
Prodam F; Benso A; Gramaglia E; Lucatello B; Riganti F; van der Lely AJ; Deghenghi R; Muccioli G; Ghigo E; Broglio F
Neuropeptides; 2008 Feb; 42(1):89-93. PubMed ID: 18061663
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat.
Sibilia V; Muccioli G; Deghenghi R; Pagani F; De Luca V; Rapetti D; Locatelli V; Netti C
J Neuroendocrinol; 2006 Feb; 18(2):122-8. PubMed ID: 16420281
[TBL] [Abstract][Full Text] [Related]
20. Proadrenomedullin N-terminal peptide and cortistatin activation of MrgX2 receptor is based on a common structural motif.
Nothacker HP; Wang Z; Zeng H; Mahata SK; O'Connor DT; Civelli O
Eur J Pharmacol; 2005 Sep; 519(1-2):191-3. PubMed ID: 16111673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
